GoodRx CFO Karsten Voermann resigns; CAO Romin Nabiey named interim CFO

GoodRx Holdings, Inc.

Karsten Voermann resigns as CFO effective Jan 17, 2025, for personal reasons, not due to any disagreement.
Romin Nabiey, current Chief Accounting Officer, appointed Interim CFO and principal financial officer.
Nabiey will continue as CAO; has been with GoodRx since 2017 in various finance roles.
Voermann's vested stock options remain exercisable through Jan 17, 2026; he retains earned 2024 bonus.
Company begins search for permanent CFO.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Romin Nabiey

Interim Chief Financial Officer

GDRX · GoodRx Holdings, Inc.

Effective: 2025-01-17
Filed: January 13, 2025, 6:59 PM ET

On January 10, 2025, the Board of Directors (the “Board”) of the Company appointed Romin Nabiey, the Company’s current Chief Accounting Officer, as Interim Chief Financial Officer of the Company, effective as of the Effective Date.

Departed

Karsten Voermann

Chief Financial Officer

GDRX · GoodRx Holdings, Inc.

Effective: 2025-01-17
Successor: Romin Nabiey
Filed: January 13, 2025, 6:59 PM ET

On January 7, 2025, Karsten Voermann submitted his resignation as Chief Financial Officer of GoodRx Holdings, Inc. (the “Company”), effective January 17, 2025 (the “Effective Date”) for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Romin Nabiey was appointed as Interim Chief Financial Officer at GoodRx Holdings, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On January 10, 2025, the Board of Directors (the “Board”) of the Company appointed Romin Nabiey, the Company’s current Chief Accounting Officer, as Interim Chief Financial Officer of the Company, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Karsten Voermann resigned as Chief Financial Officer at GoodRx Holdings, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 7, 2025, Karsten Voermann submitted his resignation as Chief Financial Officer of GoodRx Holdings, Inc. (the “Company”), effective January 17, 2025 (the “Effective Date”) for personal reasons.

View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-005050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.